Document Detail


PET/CT evaluation of cervical cancer: spectrum of disease.
MedLine Citation:
PMID:  20833849     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The prognosis of invasive cervical cancer is based on the stage, size, and histologic grade of the primary tumor and the status of the lymph nodes. Assessment of disease stage is essential in determining proper management in individual cases. In the posttherapy setting, the timely detection of recurrence is essential for guiding management and may lead to increased survival. However, the official clinical staging system of the International Federation of Gynecology and Obstetrics has inherent flaws that may lead to inaccurate staging and improper management. Combined positron emission tomography (PET)/computed tomography (CT) represents a major technologic advance, consisting of two integrated complementary modalities whose combined strength tends to overcome their respective weaknesses. PET/CT has higher sensitivity and specificity than do conventional anatomic modalities and is valuable in determining the extent of disease and detecting recurrent or residual tumor. The combination of 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET with intravenous contrast material-enhanced high-resolution CT has proved useful for avoiding the interpretative weaknesses associated with either modality alone and in increasing the accuracy of staging or restaging. Nonetheless, accurate PET/CT interpretation requires a knowledge of the characteristics of disease spread or recurrence and an awareness of various imaging pitfalls if false interpretations are to be avoided.
Authors:
Hongju Son; Arpakorn Kositwattanarerk; Monica P Hayes; Linus Chuang; Jamal Rahaman; Sherif Heiba; Josef Machac; Konstantin Zakashansky; Lale Kostakoglu
Related Documents :
20146589 - Role of pet/ct imaging in stereotactic body radiotherapy.
19022059 - Chapter 7. molecular imaging of tumor vasculature.
11973489 - Reproducibility and clinical value of 18f-fluorodeoxyglucose positron emission tomograp...
11214619 - Correlations of serum ca125 level and computerized tomography (ct) imaging with laparot...
18465129 - Detection of bone metastases in patients with prostate cancer by 18f fluorocholine and ...
18424949 - Positron emission tomography/computed tomography and whole-body magnetic resonance imag...
11371809 - Osteochondral lesions of the capitellum in pediatric patients: role of magnetic resonan...
16538139 - Revisions to the ornl series of adult and pediatric computational phantoms for use with...
17826939 - The respiratory modulation of intracranial cerebrospinal fluid pulsation observed on dy...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Radiographics : a review publication of the Radiological Society of North America, Inc     Volume:  30     ISSN:  1527-1323     ISO Abbreviation:  Radiographics     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-13     Completed Date:  2011-01-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8302501     Medline TA:  Radiographics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1251-68     Citation Subset:  IM    
Affiliation:
Department of Radiology, Mount Sinai School of Medicine, New York, NY 10029, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Image Enhancement / methods*
Internationality
Positron-Emission Tomography / methods*
Radiopharmaceuticals / diagnostic use
Subtraction Technique
Tomography, X-Ray Computed / methods*
Uterine Cervical Neoplasms / classification*,  diagnosis*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transvaginal US after bowel preparation for deeply infiltrating endometriosis: protocol, imaging app...
Next Document:  Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer.